For research use only. Not for therapeutic Use.
Cysteamine bitartrate (Mercaptamine bitartrate) is an FDA-approved cystine-depleting aminothiol agent for the treatment of nephropathic cystinosis to decrease accumulation of lysosomal cystine by engaging in disulfide exchange. In addition, cysteamine bitartrate has antioxidant properties.
Catalog Number | I047232 |
CAS Number | 27761-19-9 |
Molecular Formula | C6H13NO6S |
Purity | ≥95% |
Storage | 3 years -20°C powder |
SMILES | NCCS.OC(C(O)C(O)=O)C(O)=O |
Reference | [1] Guha S, et al. Hum Mol Genet. 2019 Jun 1;28(11):1837-1852. |